Response Gene to Complement 32 Promotes Vascular Lesion Formation Through Stimulation of Smooth Muscle Cell Proliferation and Migration

Response gene to complement 32 interacts with Smad3 to promote epithelial-mesenchymal transition of human renal tubular cells

(2011) Xia Guo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Rapid adoption of drug-eluting stents: Clinical practices and outcomes from the early drug-eluting stent era

(2010) John J. Lopez et al.   AMERICAN HEART JOURNAL

Angiotensin II–Induced Vascular Smooth Muscle Cell Migration and Growth Are Mediated by Cytochrome P450 1B1–Dependent Superoxide Generation

(2010) Fariborz A. Yaghini et al.   HYPERTENSION

Coronary Stents

(2010) Scot Garg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Different Effects of Angiotensin II and Angiotensin-(1-7) on Vascular Smooth Muscle Cell Proliferation and Migration

(2010) Feng Zhang et al.   PLoS One

Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells

(2010) C. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells

(2009) Keun Hwa Choi et al.   CARDIOVASCULAR RESEARCH

Response Gene to Complement 32, a Novel Hypoxia-Regulated Angiogenic Inhibitor

(2009) Xiaojin An et al.   CIRCULATION

Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells

(2009) Matthew Fosbrink et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

RGC-32 Mediates Transforming Growth Factor-β-induced Epithelial-Mesenchymal Transition in Human Renal Proximal Tubular Cells

(2009) Wen-Yan Huang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Drug Eluting Stents: Friend or Foe? A Review of Cellular Mechanisms Behind the Effects of Paclitaxel and Sirolimus Eluting Stents

(2008) Subroto Chatterjee et al.   CURRENT DRUG METABOLISM